Meine Merkliste
my.bionity.com  
Login  

Discovery of Benzylidene Derivatives as Potent Syk Inhibitors: Synthesis, SAR Analysis, and Biological Evaluation

Four scaffolds of varied benzylidene derivatives were synthesized and evaluated as Syk inhibitors for the treatment of rheumatoid arthritis (RA). Among these 31 compounds, 3‐benzylidene pyrrolidine‐2,5‐dione derivatives (including 12k) universally showed good Syk inhibitory activities in the low micromolar to submicromolar range. In the cellular profiling, compound 12k, the most efficient compound, showed excellent antiproliferative activity against fibroblast‐like synoviocytes (FLS)‐RA, and demonstrated potencies for suppression of IL‐6 and MMP‐3 secretion almost equal to R406 (positive control). The oral efficacy of 12k in the murine collagen‐induced arthritis model was significant, despite being weaker than R406. Taken together, all preliminary pharmacological results supported 12k as a potential small‐molecule inhibitor targeting Syk for the treatment of RA.

Four structural systems of benzylidene compounds were designed and synthesized. Analog 12k, the most efficient compound, showed excellent antiproliferative activity on fibroblast‐like synoviocytes. The oral efficacy in the murine collagen‐induced arthritis model supported 12k as a potential small‐molecule inhibitor for rheumatoid arthritis.

Autoren:   Lingling Zhang, Wei Liu, Fei Mao, Jin Zhu, Guoqiang Dong, Hualiang Jiang, Chunquan Sheng, Liyan Miao, Lixin Huang, Jian Li
Journal:   Archiv der Pharmazie
Jahrgang:   2015
Seiten:   n/a
DOI:   10.1002/ardp.201500096
Erscheinungsdatum:   01.06.2015
Fakten, Hintergründe, Dossiers
Mehr über Wiley
Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.